Active Ingredient
Lidocaine 5%
The following Structured Product Label (SPL) was submitted to the FDA by Wenzhou Yuyuan Pharmaceutical Co., Ltd. for the product Bcbcyc Numbing Cream (NDC 87786-057). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, when using, stop use, ask doctor, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Lidocaine 5%
Local anesthetic
■ for the temporary relief of local and anorectal itching and discomfort associated with hemorrhoids
■ for the temporary relief of pain, soreness, and burning
For external use only.
Certain persons can develop allergic reactions to ingredients in this product. If the symptom being treated does not subside,or if redness, irritation, swelling, pain, or other symptoms develop or increase, discontinue use and consult a doctor.
■ do not exceed the recommended daily dosage unless directed by a doctor
■ do not insert this product into the rectum by using fingers or any mechanical device or applicator
■ condition worsens or does not improve within 7 days
■ bleeding occurs
■ condition worsens or does not improve within 7 days
■ bleeding occurs
If swallowed, get medical help or contact a Poison Control Center right away.
Adults
■ when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly
■ gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product
■ apply externally to the affected area up to 6 times daily
Children under 12 years of age: consult a doctor
■ store at 20° to 25°C (68° to 77°F)
■ keep container tightly closed
■ protect from excessive heat and direct sunlight
Water,Carbomer 934,Propylene Glycol,Soybean Lecithin,Alpha-Tocopherol Acetate,Benzyl Alcohol.
* Please review the disclaimer below.